BRAIN Biotech AG
Develops custom enzymes and microbes for the food, nutrition, and chemical industries.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BRAIN Biotech AG is a leading specialist in industrial biotechnology, providing research, development, and production of bio-based solutions. The company offers end-to-end contract research services, focusing on the discovery, engineering, and manufacturing of specialized enzymes, proteins, and microbial production strains. Leveraging an advanced technology portfolio, it develops customized biosolutions for industrial partners in sectors such as food, nutrition, and chemicals. Through collaborative R&D, BRAIN Biotech helps clients accelerate innovation, reduce project complexity, and create sustainable products and processes for the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-20 15:38 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.8 KB | ||
| 2025-10-02 09:05 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 5.7 KB | ||
| 2025-09-03 09:30 |
Board/Management Information
BRAIN Biotech AG appoints Johan Jansen-Storbacka as Executive Vice President of…
|
English | 14.1 KB | ||
| 2025-08-28 07:30 |
Earnings Release
BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalys…
|
English | 20.4 KB | ||
| 2025-08-28 00:00 |
Quarterly Report
Q3 statement / Q3 financial report 2024/2025
|
English | 274.7 KB | ||
| 2025-08-25 07:30 |
Regulatory News Service
Corbion and BRAIN Biotech team to shape the future of innovation in nature-base…
|
English | 11.5 KB | ||
| 2025-07-23 08:30 |
Board/Management Information
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
|
English | 13.4 KB | ||
| 2025-06-23 08:05 |
Share Issue/Capital Change
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
|
English | 22.4 KB | ||
| 2025-05-28 07:30 |
Earnings Release
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
|
English | 20.0 KB | ||
| 2025-05-28 00:00 |
Interim Report
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
|
German | 99.2 KB | ||
| 2025-05-28 00:00 |
Interim Report
Half-yearly financial report 2024/2025
|
English | 364.5 KB | ||
| 2025-05-21 10:00 |
M&A Activity
BRAIN Biotech announces buy-out of minorities, new continental European product…
|
English | 16.2 KB | ||
| 2025-05-19 11:23 |
Report Publication Announcement
|
English | 4.1 KB | ||
| 2025-05-19 00:00 |
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
|
German | 5.8 KB | ||
| 2025-04-30 17:54 |
Earnings Release
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
|
English | 6.0 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
